Skip to content
Screener

MoonLake Immunotherapeutics MLTX Portugal — Number of operating leases

Similar metrics at other companies

The RMR Group logo
RMRNumber of operating leases
$61+1.7%
The RMR Group logo
RMRNumber of operating leases
61+1.7%
AZZ logo
AZZNumber of operating leases
161+28.8%
LPR
LPROAustin, Texas — Number of operating leases
0.30.0%
Upwork Inc. logo
UPWKPalo Alto, California — Number of operating leases
2
Upwork Inc. logo
UPWKLisbon, Portugal — Operating lease asset
$3.6M

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.55B-54.2%
Enterprise value$1.36B-57.1%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept mnlk:NumberOfOperatingLeases.

The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 8:55 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001821586-26-000007

MoonLake does not have any finance leases. As of March 31, 2026, the Company has five operating leases related to the office spaces located in (i) Dorfstrasse 29, 6300, Zug, Switzerland (comprised of two leases), (ii) 95 Regent Street, CB2 1AW, Cambridge, England, United Kingdom, and (iii) Rua Manuel Pinto de Azevedo 860, 4150-335, Porto, Portugal (comprised of two leases). The operating leases are recognized over a straight-line basis over the lease term commencing on the date the Company has the right to use the leased property. Right-of-use assets and lease liabilities are measured at the lease commencement date based on the present value of the remaining lease payments over the lease term, determined using the discount rate for the lease at the commencement date. Because the rate implicit in the leases is not readily determinable, the Company uses the incremental borrowing rate as the discount rate, which approximates the interest rate at which the Company could borrow on a collateralized basis with similar terms and payments and in similar economic environments.

Item 1. Financial Statements (Unaudited)

FAQ

What is MoonLake Immunotherapeutics's portugal — number of operating leases?
MoonLake Immunotherapeutics (MLTX) reported portugal — number of operating leases of 2 in Q1 2026.
How has MoonLake Immunotherapeutics's portugal — number of operating leases changed year-over-year?
MoonLake Immunotherapeutics's portugal — number of operating leases increased by 300.0% year-over-year, from 0.5 to 2.
What does portugal — number of operating leases mean?
This metric represents the total count of active operating lease agreements held by the company within the specified geographic region. It provides insight into the company's physical footprint and commitment to leased infrastructure in that market. Monitoring this figure helps investors understand the scale of operations and the associated fixed-cost obligations in a particular territory.

Ask your AI about MoonLake Immunotherapeutics's portugal — number of operating leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude